Mednet Logo
HomeNephrology
Nephrology

Nephrology

Clinical discussions on kidney disease management, dialysis, transplantation, and electrolyte disorders.

Recent Discussions

What is your approach to recurrent uric acid stone formers who have a persistently acidic urine pH and are unable to tolerate potassium citrate?

1 Answers

Mednet Member
Mednet Member
Nephrology · Mayo Clinic

I use sodium bicarbonate. I teach the patient how to titrate the dose using pH dipsticks to get the urine pH >6.0. Although sodium may increase urine calcium excretion, in uric acid stone formers, this is not an issue. Long experience with sodium bicarbonate tells us it does not raise blood pressure...

Do you avoid ESAs in patients with end stage kidney disease who also have heart failure due to increased risk of stroke?

2 Answers

Mednet Member
Mednet Member
Nephrology · IU Health

If the question is whether I avoid ESAs in patients with ESKD who also have heart failure, the answer is no for several reasons. The warning in the ESA package insert regarding using ESAs with caution in patients with heart failure (HF) comes from the CHOIR study (Singh, et al., PMID 17108343) of no...

Do you give a short-acting antihypertensive before starting outpatient hemodialysis on an asymptomatic ESKD patient with a predialysis blood pressure of more than 200/100?

1 Answers

Mednet Member
Mednet Member
Nephrology · University Of California San Francisco Medical Center At Parnassus

I rarely use short-acting antihypertensive agents. I usually give long-acting calcium channel blockers, b-blockers or ace inhibitors if the blood pressure is very high. Ultimately the best option would be to remove more and more fluid slowly over time if patient can tolerate it. However, I find flui...

What is your approach to management of recurrent nephrolithiasis in patients with mixed composition uric acid and calcium phosphate stones?

3 Answers

Mednet Member
Mednet Member
Nephrology · Medical College of Wisconsin

Likely the urine pH is more typically low in such patients, since the uric acid components will dissolve during periods of higher pH. Consequently, the appearance of uric acid crystals in the stone suggests that the urine pH is more typically low. Drinking more fluid to cause more dilute urine alway...

Are there patients with recurrent nephrolithiasis for who you recommend magnesium supplementation to reduce stone risk?

1
1 Answers

Mednet Member
Mednet Member
Nephrology · Medical College of Wisconsin

While magnesium supplementation may be justified on theoretical grounds, I have never used magnesium supplements as a treatment exclusively for kidney stones. I have only ever seen or used magnesium supplementation in stone patients that had concurrent hypomagnesemia.

What is the current recommendation for using thiazide diuretics in patients with calcium oxalate stone disease, given the negative results of the NOSTONE trial?

4 Answers

Mednet Member
Mednet Member
Nephrology · NYU Grossman School of Medicine

This trial will have no effect on my practice. Seven of 10 previous studies of thiazides for stones were positive, as was a meta-analysis. My preference is for the longer-acting drugs indapamide and chlorthalidone; I haven't used HCTZ which is probably a twice-a-day drug, for some years. Note that t...

Do you recommend taking any unique approaches to managing patients with persistent hypertension following bilateral renal artery stenting?

1
1 Answers

Mednet Member
Mednet Member
Nephrology · UAB Medicine

Yes, I will be more aggressive with lipid management, sometimes using PCSK9-INH in addition to a statin, if the cause of the renal artery stenosis was atherosclerotic-related. Also, I typically get yearly ultrasounds to evaluate the patency of the renal artery stents. From a management perspective, ...

What are your next steps when managing patients with suspected Gitelman syndrome for whom genetic testing reveals variants of uncertain significance or novel mutations not well characterized?

2 Answers

Mednet Member
Mednet Member
Nephrology · Rush Medical College

If the patient had a clinical syndrome that fit the Gitelman phenotype I would totally treating as such.

When would you recommend adding peritoneal dialysis to a patient with oxalosis who is already receiving hemodialysis?

1 Answers

Mednet Member
Mednet Member
Nephrology · Mayo Clinic

Tang et al., PMID 24776840I have never done this. The amount of oxalate cleared by peritoneal dialysis is a very small fraction of the amount cleared by hemodialysis. In general, among patients with oxalosis, the oxalate is well cleared from the blood on hemodialysis, but oxalate has a very large vo...

Would you recommend AV fistula placement in a CKD Stage 5 patient who is over the age of 80?

2 Answers

Mednet Member
Mednet Member
Nephrology · Jersey Shore University Medical Center

Depends. If this is an active 80-year-old, then creating a distal fistula (radial-cephalic, when vessels are available) would be ideal compared to a catheter. For someone with limited life expectancy, an alternative (graft or catheter) may be acceptable.